Skip to content

Reduction in bleeding in middle ear surgeries with target control infusion with propofol, and comparison with dexmedetomidine and fentanyl fixed dose

TARGET CONTROLLED INFUSION WITH PROPOFOL IN MIDDLE EAR SURGERIES -A RANDOMISED CONTROLLED DOUBLE-BLIND TRIAL ON REDUCTION IN SURGICAL BLEEDING WITH FIXED DOSE INTRAVENOUS INFUSION OF FENTANYL OR DEXMEDETOMIDINEâ??

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049466
Enrollment
62
Registered
2023-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Fixed dose intravenous infusion of dexmedetomidine: Inj. Dexmedetomidine is started with bolus 1mcg/kg and followed by infusion (0.5mcg/kg/hr) before activation of proof old administrat

Sponsors

Vijayanagar institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients undergoing middle year surgeries of 18-60 years of age. 2.American society of anaesthesiologists physical status I and II 3. Non obese (BMI- 18.5-29.9)

Exclusion criteria

Exclusion criteria: 1.Refusal of patients consent 2.Patients with significant systemic disease 3.Patients on long term and concurrent sedative intake

Design outcomes

Primary

MeasureTime frame
Reduction in surgical bleedingTimepoint: Reduction in surgical bleeding 1) post intubation (every 5 min) 2) following 24 hours after surgery

Secondary

MeasureTime frame
changes in systolic BP, diastolic BP, mean BP, heart rate, SP02, EtCO2. Total propofol used. Correlation of TCI propofol with the state entropy levels. Incidence of postoperative nausea and vomiting. Timepoint: pre induction intubation post intubation every 5 min intraoperative

Countries

India

Contacts

Public ContactReethesh s moorman

Vijayanagar Institute of medical sciences

sbalabhaskar@gmail.com9880012349

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026